Erlotinib Tillomed

Erlotinib Tillomed is an oral medication used to treat certain types of cancer. This targeted therapy works by inhibiting specific proteins involved in cancer cell growth.

Erlotinib Tillomed is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It is a type of tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' and the answer lies in its ability to interfere with the cancer's progression at the cellular level.

Common effects of Erlotinib Tillomed may include skin rash, diarrhea, and fatigue. Some users also report appetite loss and dry skin. These effects can vary in severity and duration, depending on individual responses to the medication.

Erlotinib Tillomed should be handled with care, stored properly, and used as directed by a healthcare professional. It is important to follow safety guidelines to minimize potential risks. Patients with pre-existing conditions should consult their healthcare provider before starting this medication.

Erlotinib Tillomed may interact with certain medications, including those that induce or inhibit CYP3A4 enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect the metabolism of Erlotinib.